Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial
Clinical trial NCT01218568 · COMPLETED
Trial details
- NCT number
- NCT01218568
- Sponsor
- Institute of Liver and Biliary Sciences, India
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-09-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.